Recent studies have revealed several possible mechanisms related to the survival and growth of metastatic castration‐resistant PCa (mCRPC) cells without androgen, such as amplification of androgen receptor (AR), expression of constitutively active AR splice variants (AR‐V) and de novo intratumoral androgen biosynthesis.2, 3. The gene discussed is AR; the disease is posterior cortical atrophy.